CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: PTGIS (ImmuneEditome ID:5740)

1. Gene summary of enriched editing regions for PTGIS

check button Gene summary
Gene informationGene symbol

PTGIS

Gene ID

5740

GeneSynonymsCYP8|CYP8A1|PGIS|PTGI
GeneCytomap

20q13.13

GeneTypeprotein-coding
GeneDescriptionprostacyclin synthase|cytochrome P450, family 8, subfamily A, polypeptide 1|hydroperoxy icosatetraenoate dehydratase|prostaglandin I2 (prostacyclin) synthase
GeneModificationdate20230329
UniprotIDQ16647
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr20:49504482-49505109:-ENST00000244043.4ENSG00000124212.5PTGISUTR3MER113,AluSp,AluYchr20:49504482-49505109:-.alignment
chr20:49506421-49506694:-ENST00000244043.4ENSG00000124212.5PTGISUTR3AluSz6,OldhAT1chr20:49506421-49506694:-.alignment
chr20:49533745-49534968:-ENST00000478971.1ENSG00000124212.5PTGISncRNA_intronicAluJb,(AT)n,L1ME4b,AluSz,MIRbchr20:49533745-49534968:-.alignment
chr20:49536553-49537647:-ENST00000478971.1ENSG00000124212.5PTGISncRNA_intronicL1ME3G,AluSx,MER5A,MIR,AluSx1chr20:49536553-49537647:-.alignment
chr20:49565050-49565570:-ENST00000478971.1ENSG00000124212.5PTGISncRNA_intronicAluY,AluJrchr20:49565050-49565570:-.alignment


Top

2. Tumor-specific enriched editing regions for PTGIS


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot
ENSG00000124212.5,PTGISBRCAEAG1.1185e-08image
chr20:49504482-49505109:-LUADEER9.8512e-03image
ENSG00000124212.5,PTGISLUADEAG2.3507e-04image
ENSG00000124212.5,PTGISLUSCEAG4.0487e-09image
ENSG00000124212.5,PTGISSTADEAG3.9248e-02image
ENSG00000124212.5,PTGISUCECEAG5.9978e-05image


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
chr20:49504482-49505109:-LIHCPathEER4.1834e-027.1822e-030.3304image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot

Top

3. Enriched editing regions and immune related genes for PTGIS


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

4. Enriched editing regions and immune related splicing for PTGIS


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
ENSG00000124212.5,PTGIS
BRCAEAGIRENSG00000079435.5chr1942401506:42402075:42402606:424030310.12333.5509e-031.0432e-280.4219imageNDGCR8;DKC1;EIF4A3;EWSR1;FBL;FUS;HNRNPL;IGF2BP2;NOP56;NOP58;PTBP1;RBFOX2;TAF15;TARDBPNADendritic_cells_activatedGSVA_HALLMARK_MYOGENESIS

More results



Top

5. Enriched editing regions and immune infiltration for PTGIS


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chr20:49504482-49505109:-BLCAEERNK_cells_resting7.1443e-030.2050image
ENSG00000124212.5,PTGISBLCAEAGNK_cells_resting4.1378e-040.2598image
chr20:49504482-49505109:-BRCAEERMast_cells_resting1.1911e-020.0935image
ENSG00000124212.5,PTGISBRCAEAGT_cells_CD82.3802e-02-0.0801image
chr20:49504482-49505109:-CESCEERB_cells_naive4.3676e-02-0.3840image
ENSG00000124212.5,PTGISCESCEAGT_cells_regulatory_(Tregs)1.5620e-050.7016image
ENSG00000124212.5,PTGISCHOLEAGB_cells_memory4.0919e-030.6125image
chr20:49504482-49505109:-COADEERDendritic_cells_activated4.3431e-080.6135image
ENSG00000124212.5,PTGISCOADEAGDendritic_cells_activated3.7015e-060.5057image
chr20:49504482-49505109:-ESCAEERDendritic_cells_activated4.8391e-030.3428image
ENSG00000124212.5,PTGISESCAEAGDendritic_cells_activated1.1353e-040.4392image
chr20:49504482-49505109:-GBMEERMast_cells_activated1.1023e-020.5093image
chr20:49506421-49506694:-GBMEERDendritic_cells_resting3.1055e-050.7925image
chr20:49506421-49506694:-HNSCEERNK_cells_resting7.5878e-030.3443image
chr20:49504482-49505109:-KIRCEERDendritic_cells_activated6.5101e-030.2156image
ENSG00000124212.5,PTGISKIRCEAGEosinophils2.2354e-070.3836image
ENSG00000124212.5,PTGISKIRPEAGDendritic_cells_resting2.0944e-02-0.2838image
ENSG00000124212.5,PTGISLIHCEAGT_cells_CD4_memory_activated2.1149e-020.2732image
chr20:49504482-49505109:-LUADEEREosinophils2.9997e-030.1700image
ENSG00000124212.5,PTGISLUADEAGEosinophils8.9649e-030.1415image
chr20:49504482-49505109:-LUSCEERB_cells_memory1.1196e-020.1550image
chr20:49504482-49505109:-MESOEERT_cells_regulatory_(Tregs)8.3401e-03-0.2949image
chr20:49506421-49506694:-MESOEERMacrophages_M03.9552e-02-0.2399image
ENSG00000124212.5,PTGISMESOEAGMacrophages_M21.8932e-030.3442image
chr20:49504482-49505109:-OVEERDendritic_cells_activated1.1747e-020.1608image
ENSG00000124212.5,PTGISOVEAGDendritic_cells_activated1.9464e-020.1465image
chr20:49504482-49505109:-PAADEERMonocytes5.9518e-030.2179image
chr20:49506421-49506694:-PAADEERT_cells_CD4_memory_resting3.5985e-030.2471image
ENSG00000124212.5,PTGISPAADEAGMast_cells_activated1.4372e-030.2484image
chr20:49504482-49505109:-PCPGEERT_cells_regulatory_(Tregs)3.4536e-020.3872image
ENSG00000124212.5,PTGISPCPGEAGT_cells_CD89.7723e-030.4194image
chr20:49504482-49505109:-PRADEERT_cells_gamma_delta5.1447e-030.1434image
ENSG00000124212.5,PTGISPRADEAGT_cells_gamma_delta8.7761e-030.1314image
chr20:49504482-49505109:-READEERPlasma_cells1.1061e-020.4432image
ENSG00000124212.5,PTGISREADEAGMonocytes7.3289e-030.4517image
chr20:49504482-49505109:-SARCEERMonocytes1.4376e-02-0.1687image
ENSG00000124212.5,PTGISSARCEAGT_cells_CD4_memory_resting2.1503e-02-0.1567image
chr20:49504482-49505109:-SKCMEERMast_cells_activated7.7394e-030.1678image
ENSG00000124212.5,PTGISSKCMEAGT_cells_gamma_delta3.7713e-020.1263image
chr20:49504482-49505109:-STADEERB_cells_naive2.6366e-03-0.1957image
ENSG00000124212.5,PTGISSTADEAGB_cells_naive4.4259e-03-0.1780image
chr20:49506421-49506694:-TGCTEERMacrophages_M22.7272e-07-0.5988image
ENSG00000124212.5,PTGISTGCTEAGB_cells_naive1.5703e-030.3285image
chr20:49504482-49505109:-THCAEERT_cells_CD83.4460e-030.3194image
ENSG00000124212.5,PTGISTHCAEAGT_cells_CD81.8750e-020.2395image
chr20:49504482-49505109:-UCSEERNK_cells_activated1.8439e-02-0.3258image


Top

6. Enriched editing regions and immune gene sets for PTGIS


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot
ENSG00000124212.5,PTGISBRCAEAG5.3546e-05image5.9151e-04-0.1215image
chr20:49504482-49505109:-STADEER1.7913e-02image4.9735e-03-0.1830image
ENSG00000124212.5,PTGISSTADEAG4.8114e-04image7.7640e-05-0.2453image


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
ENSG00000124212.5,PTGISBLCAGSVA_HALLMARK_MYC_TARGETS_V2EAG4.5467e-030.2100image
chr20:49504482-49505109:-BLCAGSVA_HALLMARK_HEDGEHOG_SIGNALINGEER3.9347e-02-0.1577image
ENSG00000124212.5,PTGISBRCAGSVA_HALLMARK_MYOGENESISEAG1.2357e-07-0.1861image
chr20:49504482-49505109:-BRCAGSVA_HALLMARK_PROTEIN_SECRETIONEER3.2226e-030.1095image
ENSG00000124212.5,PTGISCESCGSVA_HALLMARK_PROTEIN_SECRETIONEAG2.6745e-02-0.4042image
chr20:49504482-49505109:-CESCGSVA_HALLMARK_XENOBIOTIC_METABOLISMEER2.0799e-020.4347image
ENSG00000124212.5,PTGISCHOLGSVA_HALLMARK_ALLOGRAFT_REJECTIONEAG2.7809e-02-0.4913image
chr20:49504482-49505109:-COADGSVA_HALLMARK_MYOGENESISEER2.4575e-03-0.3667image
ENSG00000124212.5,PTGISCOADGSVA_HALLMARK_MYOGENESISEAG2.3775e-04-0.4122image
ENSG00000124212.5,PTGISESCAGSVA_HALLMARK_UV_RESPONSE_DNEAG4.5431e-03-0.3308image
ENSG00000124212.5,PTGISGBMGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG9.3041e-030.4334image
chr20:49506421-49506694:-GBMGSVA_HALLMARK_HEDGEHOG_SIGNALINGEER2.8250e-020.4901image
chr20:49504482-49505109:-HNSCGSVA_HALLMARK_PEROXISOMEEER1.1667e-030.3751image
ENSG00000124212.5,PTGISKIRCGSVA_HALLMARK_MYOGENESISEAG3.0779e-02-0.1652image
chr20:49504482-49505109:-KIRPGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER3.2440e-02-0.3000image
chr20:49504482-49505109:-LGGGSVA_HALLMARK_BILE_ACID_METABOLISMEER8.2537e-030.4457image
ENSG00000124212.5,PTGISLGGGSVA_HALLMARK_DNA_REPAIREAG2.2586e-03-0.4486image
ENSG00000124212.5,PTGISLIHCGSVA_HALLMARK_COAGULATIONEAG2.1290e-02-0.2729image
ENSG00000124212.5,PTGISLUADGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEAG2.7415e-02-0.1196image
ENSG00000124212.5,PTGISLUSCGSVA_HALLMARK_E2F_TARGETSEAG2.4502e-040.2116image
chr20:49506421-49506694:-MESOGSVA_HALLMARK_UV_RESPONSE_DNEER3.9666e-020.2397image
ENSG00000124212.5,PTGISOVGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG3.1563e-060.2876image
chr20:49504482-49505109:-OVGSVA_HALLMARK_UV_RESPONSE_DNEER8.0332e-06-0.2809image
chr20:49504482-49505109:-PAADGSVA_HALLMARK_PANCREAS_BETA_CELLSEER3.3770e-020.1690image
chr20:49506421-49506694:-PAADGSVA_HALLMARK_MYC_TARGETS_V1EER2.1341e-02-0.1965image
ENSG00000124212.5,PTGISPAADGSVA_HALLMARK_ALLOGRAFT_REJECTIONEAG3.8912e-02-0.1624image
chr20:49504482-49505109:-PCPGGSVA_HALLMARK_ANGIOGENESISEER1.2796e-02-0.4491image
ENSG00000124212.5,PTGISPCPGGSVA_HALLMARK_HYPOXIAEAG7.6445e-04-0.5289image
chr20:49504482-49505109:-PRADGSVA_HALLMARK_MITOTIC_SPINDLEEER7.3811e-030.1374image
ENSG00000124212.5,PTGISPRADGSVA_HALLMARK_MYOGENESISEAG1.1446e-11-0.3320image
chr20:49504482-49505109:-READGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEER3.1636e-02-0.3806image
ENSG00000124212.5,PTGISREADGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG2.6820e-020.3796image
chr20:49504482-49505109:-SARCGSVA_HALLMARK_DNA_REPAIREER1.3097e-02-0.1710image
ENSG00000124212.5,PTGISSKCMGSVA_HALLMARK_ANGIOGENESISEAG2.0503e-02-0.1407image
chr20:49504482-49505109:-STADGSVA_HALLMARK_MYOGENESISEER1.5406e-04-0.2449image
ENSG00000124212.5,PTGISSTADGSVA_HALLMARK_MYOGENESISEAG3.6211e-07-0.3127image
chr20:49506421-49506694:-TGCTGSVA_HALLMARK_ANGIOGENESISEER2.4117e-11-0.7261image
ENSG00000124212.5,PTGISTGCTGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEAG3.7320e-08-0.5409image
chr20:49504482-49505109:-TGCTGSVA_HALLMARK_APOPTOSISEER2.6290e-02-0.2469image
chr20:49504482-49505109:-UCSGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEER3.7078e-020.2899image
ENSG00000124212.5,PTGISUCSGSVA_HALLMARK_G2M_CHECKPOINTEAG6.0517e-030.3757image
chr20:49506421-49506694:-UCSGSVA_HALLMARK_G2M_CHECKPOINTEER3.1798e-020.3400image


Top

7. Enriched editing regions and drugs for PTGIS


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000124212.5,PTGISBLCAErlotinibEAG1.1823e-02-0.1868image
chr20:49504482-49505109:-BRCACEP.701EER7.8917e-040.1247image
ENSG00000124212.5,PTGISBRCACEP.701EAG8.4947e-090.2024image
chr20:49504482-49505109:-CESCJNK.9LEER7.3272e-03-0.4956image
ENSG00000124212.5,PTGISCESCErlotinibEAG3.0672e-04-0.6141image
ENSG00000124212.5,PTGISCOADJW.7.52.1EAG1.6960e-030.3564image
chr20:49504482-49505109:-COADGSK.650394EER1.1678e-030.3911image
ENSG00000124212.5,PTGISGBMCMKEAG3.7086e-020.3538image
chr20:49506421-49506694:-GBMAZD.0530EER1.7326e-020.5255image
ENSG00000124212.5,PTGISHNSCBMS.754807EAG6.3601e-030.2888image
chr20:49504482-49505109:-HNSCBX.795EER5.8677e-030.3216image
chr20:49506421-49506694:-HNSCAZD7762EER1.9322e-020.3038image
chr20:49504482-49505109:-KIRCAZD6244EER6.0794e-04-0.2698image
ENSG00000124212.5,PTGISKIRCBMS.536924EAG1.8585e-050.3229image
chr20:49504482-49505109:-KIRPAZD.2281EER1.5583e-020.3370image
ENSG00000124212.5,PTGISKIRPAZD.2281EAG6.7481e-040.4079image
ENSG00000124212.5,PTGISLGGBMS.509744EAG2.3150e-030.4476image
chr20:49504482-49505109:-LGGGSK.650394EER2.1545e-020.3928image
ENSG00000124212.5,PTGISLIHCABT.888EAG4.3817e-02-0.2471image
chr20:49504482-49505109:-LIHCABT.888EER3.7296e-02-0.2609image
chr20:49504482-49505109:-LUADAxitinibEER2.5319e-030.1729image
ENSG00000124212.5,PTGISLUADCEP.701EAG1.4203e-040.2049image
ENSG00000124212.5,PTGISLUSCLFM.A13EAG1.3179e-030.1858image
chr20:49504482-49505109:-LUSCBryostatin.1EER1.1602e-020.1543image
chr20:49504482-49505109:-MESOCGP.082996EER3.2968e-020.2402image
ENSG00000124212.5,PTGISMESOA.443654EAG2.4696e-020.2526image
chr20:49506421-49506694:-MESOBMS.536924EER3.8185e-030.3323image
chr20:49504482-49505109:-OVBX.795EER5.4356e-050.2549image
ENSG00000124212.5,PTGISOVBX.795EAG8.8870e-060.2747image
ENSG00000124212.5,PTGISPAADA.770041EAG2.9773e-040.2841image
chr20:49506421-49506694:-PAADA.770041EER2.3197e-020.1968image
chr20:49504482-49505109:-PAADA.770041EER1.1403e-030.2598image
ENSG00000124212.5,PTGISPCPGAZD.0530EAG1.3120e-020.4096image
ENSG00000124212.5,PTGISPRADAZD.0530EAG4.3406e-060.2317image
chr20:49504482-49505109:-PRADAG.014699EER1.1539e-02-0.1296image
chr20:49504482-49505109:-READFTI.277EER1.5820e-030.5356image
ENSG00000124212.5,PTGISREADFTI.277EAG6.3887e-040.5561image
ENSG00000124212.5,PTGISSARCMetforminEAG1.4118e-030.2164image
chr20:49504482-49505109:-SARCMetforminEER8.3229e-050.2682image
ENSG00000124212.5,PTGISSKCMABT.888EAG3.9228e-03-0.1747image
chr20:49504482-49505109:-SKCMABT.888EER1.8087e-02-0.1491image
chr20:49504482-49505109:-STADBAY.61.3606EER9.9582e-050.2516image
ENSG00000124212.5,PTGISSTADAG.014699EAG3.6092e-050.2566image
ENSG00000124212.5,PTGISTGCTCGP.60474EAG6.9878e-060.4540image
chr20:49506421-49506694:-TGCTLenalidomideEER4.2280e-09-0.6633image
chr20:49504482-49505109:-TGCTCGP.60474EER9.7243e-030.2857image
ENSG00000124212.5,PTGISTHCAMethotrexateEAG4.5275e-03-0.2934image
chr20:49504482-49505109:-THCAMethotrexateEER8.2704e-04-0.3687image
ENSG00000124212.5,PTGISUCECCHIR.99021EAG1.1317e-020.4232image
chr20:49504482-49505109:-UCECCHIR.99021EER4.1221e-020.3688image
ENSG00000124212.5,PTGISUCSEtoposideEAG1.3883e-02-0.3392image
chr20:49506421-49506694:-UCSDoxorubicinEER1.1792e-02-0.3944image
chr20:49504482-49505109:-UCSJNJ.26854165EER4.1740e-02-0.2834image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType
chr20:49504482-49505109:-ENST00000244043.4Q16647DB00812PhenylbutazoneSmallMoleculeDrug
chr20:49504482-49505109:-ENST00000244043.4Q16647DB01240EpoprostenolSmallMoleculeDrug
chr20:49506421-49506694:-ENST00000244043.4Q16647DB00812PhenylbutazoneSmallMoleculeDrug
chr20:49506421-49506694:-ENST00000244043.4Q16647DB01240EpoprostenolSmallMoleculeDrug